Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer

BETHESDA, Md., April 12, 2023 -- Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced the appointment of... | June 19, 2023

Related Keywords

Evan Ballantyne ,Matthias Alder ,C Evan Ballantyne ,Salvatore Calabrese ,Michaelj Fox Foundation For Parkinson Research ,Health Science ,Gain Therapeutics Inc ,Orchestra Biomed Inc ,Silverstein Foundation For Parkinson ,Exchange Commission On ,Nasdaq ,Synthetic Biologics Inc ,Cerecin Inc ,Clinical Data Inc ,Exchange Commission ,Company Annual Report On Form ,University Of Western Ontario ,University Of Windsor ,European Union Horizon ,Oncxerna Therapeutics Inc ,Agenus Inc ,Chief Financial Officer ,Chief Financial ,Chief Executive Officer ,Oncxerna Therapeutics ,Orchestra Biomed ,Executive Vice President ,Clinical Data ,Forest Laboratories ,Synthetic Biologics ,Western Ontario ,Equity Incentive Plan ,Transition Date ,Inducement Awards ,Inducement Plan ,Nasdaq Listing ,Gain Therapeutics ,Silverstein Foundation ,Private Securities Litigation Reform Act ,Annual Report ,Media Contact ,